Insider Selling: CME Group Director Unloads 2,000 Shares of Stock (CME)
CME Group (NYSE:CME) Director C C. Odom II sold 2,000 shares of CME Group stock in a transaction dated Thursday, February 6th. The shares were sold at an average price of $73.59, for a total transaction of $147,180.00. Following the transaction, the director now directly owns 6,003 shares in the company, valued at approximately $441,761. The transaction was disclosed in a document filed with the SEC, which can be accessed through this link.
Shares of CME Group (NYSE:CME) traded down 0.38% on Friday, hitting $75.69. 1,863,136 shares of the company’s stock traded hands. CME Group has a 52 week low of $56.60 and a 52 week high of $84.71. The stock’s 50-day moving average is $76.72 and its 200-day moving average is $75.83. The company has a market cap of $25.383 billion and a price-to-earnings ratio of 26.65.
CME Group (NYSE:CME) last issued its quarterly earnings data on Tuesday, February 4th. The company reported $0.64 earnings per share for the quarter, missing the analysts’ consensus estimate of $0.68 by $0.04. The company had revenue of $687.00 million for the quarter, compared to the consensus estimate of $691.29 million. During the same quarter in the prior year, the company posted $0.63 earnings per share. The company’s quarterly revenue was up 3.9% on a year-over-year basis. On average, analysts predict that CME Group will post $3.58 earnings per share for the current fiscal year.
The company also recently declared a quarterly dividend, which is scheduled for Tuesday, March 25th. Shareholders of record on Monday, March 10th will be given a dividend of 0.47 per share. This represents a $1.88 dividend on an annualized basis and a yield of 2.48%. The ex-dividend date of this dividend is Thursday, March 6th. This is a positive change from CME Group’s previous quarterly dividend of $0.45.
A number of analysts have recently weighed in on CME shares. Analysts at Zacks reiterated a “neutral” rating on shares of CME Group in a research note to investors on Wednesday. They now have a $77.00 price target on the stock. Separately, analysts at BMO Capital Markets cut their EPS estimates on shares of CME Group in a research note on Wednesday. They now have an “outperform” rating and a $85.00 price target on the stock. Finally, analysts at Citigroup Inc. downgraded shares of CME Group from a “buy” rating to a “neutral” rating in a research note to investors on Wednesday, January 8th. They now have a $82.00 price target on the stock. One equities research analyst has rated the stock with a sell rating, twelve have assigned a hold rating and eight have given a buy rating to the company. CME Group currently has a consensus rating of “Hold” and an average price target of $71.34.
CME Group Inc (NYSE:CME) offers a range of global products across all asset classes based on interest rates, equity indexes, foreign exchange, energy, agricultural commodities, metals, weather and real estate.
Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.